NBP
NovaBridge BiosciencesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$282.46M
P/E Ratio
—
EPS
$-0.48
Beta
1.74
52W High
$6.79
52W Low
$0.63
50-Day MA
$3.15
200-Day MA
$3.66
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.68
PEG Ratio
—
About NovaBridge Biosciences
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-94.20M |
| Operating Margin | 0.00% |
| Return on Equity | -40.90% |
| Return on Assets | -24.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.00 |
| Price-to-Book | 1.08 |
| Price-to-Sales (TTM) | 25.39 |
| EV/Revenue | - |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $115.29M |
| Float | $147.74M |
| % Insiders | 21.39% |
| % Institutions | 42.88% |
Historical Volatility
HV 10-Day
89.79%
HV 20-Day
75.57%
HV 30-Day
86.39%
HV 60-Day
74.42%
HV Rank
36.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.25 target)
4
BuyData last updated: 4/9/2026